BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27080473)

  • 1. AIP mutations impair AhR signaling in pituitary adenoma patients fibroblasts and in GH3 cells.
    Lecoq AL; Viengchareun S; Hage M; Bouligand J; Young J; Boutron A; Zizzari P; Lombès M; Chanson P; Kamenický P
    Endocr Relat Cancer; 2016 May; 23(5):433-43. PubMed ID: 27080473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.
    Jaffrain-Rea ML; Angelini M; Gargano D; Tichomirowa MA; Daly AF; Vanbellinghen JF; D'Innocenzo E; Barlier A; Giangaspero F; Esposito V; Ventura L; Arcella A; Theodoropoulou M; Naves LA; Fajardo C; Zacharieva S; Rohmer V; Brue T; Gulino A; Cantore G; Alesse E; Beckers A
    Endocr Relat Cancer; 2009 Sep; 16(3):1029-43. PubMed ID: 19556287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of AIP-related molecules in elucidation of cellular pathways in pituitary adenomas.
    Heliövaara E; Raitila A; Launonen V; Paetau A; Arola J; Lehtonen H; Sane T; Weil RJ; Vierimaa O; Salmela P; Tuppurainen K; Mäkinen M; Aaltonen LA; Karhu A
    Am J Pathol; 2009 Dec; 175(6):2501-7. PubMed ID: 19850893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
    Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
    Leontiou CA; Gueorguiev M; van der Spuy J; Quinton R; Lolli F; Hassan S; Chahal HS; Igreja SC; Jordan S; Rowe J; Stolbrink M; Christian HC; Wray J; Bishop-Bailey D; Berney DM; Wass JA; Popovic V; Ribeiro-Oliveira A; Gadelha MR; Monson JP; Akker SA; Davis JR; Clayton RN; Yoshimoto K; Iwata T; Matsuno A; Eguchi K; Musat M; Flanagan D; Peters G; Bolger GB; Chapple JP; Frohman LA; Grossman AB; Korbonits M
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2390-401. PubMed ID: 18381572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas.
    Georgitsi M; De Menis E; Cannavò S; Mäkinen MJ; Tuppurainen K; Pauletto P; Curtò L; Weil RJ; Paschke R; Zielinski G; Wasik A; Lubinski J; Vahteristo P; Karhu A; Aaltonen LA
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):621-7. PubMed ID: 18410548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations.
    Jaffrain-Rea ML; Rotondi S; Turchi A; Occhi G; Barlier A; Peverelli E; Rostomyan L; Defilles C; Angelini M; Oliva MA; Ceccato F; Maiorani O; Daly AF; Esposito V; Buttarelli F; Figarella-Branger D; Giangaspero F; Spada A; Scaroni C; Alesse E; Beckers A
    Endocr Relat Cancer; 2013 Oct; 20(5):753-66. PubMed ID: 23940012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aryl Hydrocarbon Receptor-Interacting Protein (AIP) N-Terminus Gene Mutations Identified in Pituitary Adenoma Patients Alter Protein Stability and Function.
    Formosa R; Vassallo J
    Horm Cancer; 2017 Jun; 8(3):174-184. PubMed ID: 28255869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of aryl hydrocarbon receptor signaling in childhood obesity.
    Shahin NN; Abd-Elwahab GT; Tawfiq AA; Abdelgawad HM
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158714. PubMed ID: 32302739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Mutation of Aryl Hydrocarbon Receptor Interacting Protein Gene Associated with Familial Isolated Pituitary Adenoma Mediates Tumor Invasion and Growth Hormone Hypersecretion.
    Cai F; Hong Y; Xu J; Wu Q; Reis C; Yan W; Wang W; Zhang J
    World Neurosurg; 2019 Mar; 123():e45-e59. PubMed ID: 30447469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl-hydrocarbon receptor activity modulates prolactin expression in the pituitary.
    Moran TB; Brannick KE; Raetzman LT
    Toxicol Appl Pharmacol; 2012 Nov; 265(1):139-45. PubMed ID: 22975028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIP and its interacting partners.
    Trivellin G; Korbonits M
    J Endocrinol; 2011 Aug; 210(2):137-55. PubMed ID: 21454441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell Line.
    Fukuda T; Tanaka T; Hamaguchi Y; Kawanami T; Nomiyama T; Yanase T
    PLoS One; 2016; 11(10):e0164131. PubMed ID: 27706259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.
    Daly AF; Vanbellinghen JF; Khoo SK; Jaffrain-Rea ML; Naves LA; Guitelman MA; Murat A; Emy P; Gimenez-Roqueplo AP; Tamburrano G; Raverot G; Barlier A; De Herder W; Penfornis A; Ciccarelli E; Estour B; Lecomte P; Gatta B; Chabre O; Sabaté MI; Bertagna X; Garcia Basavilbaso N; Stalldecker G; Colao A; Ferolla P; Wémeau JL; Caron P; Sadoul JL; Oneto A; Archambeaud F; Calender A; Sinilnikova O; Montañana CF; Cavagnini F; Hana V; Solano A; Delettieres D; Luccio-Camelo DC; Basso A; Rohmer V; Brue T; Bours V; Teh BT; Beckers A
    J Clin Endocrinol Metab; 2007 May; 92(5):1891-6. PubMed ID: 17244780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aip regulates cAMP signalling and GH secretion in GH3 cells.
    Formosa R; Xuereb-Anastasi A; Vassallo J
    Endocr Relat Cancer; 2013 Aug; 20(4):495-505. PubMed ID: 23702468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of the gene for the aryl hydrocarbon receptor-interacting protein in pituitary adenomas.
    Cazabat L; Guillaud-Bataille M; Bertherat J; Raffin-Sanson ML
    Horm Res; 2009; 71(3):132-41. PubMed ID: 19188737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families.
    Igreja S; Chahal HS; King P; Bolger GB; Srirangalingam U; Guasti L; Chapple JP; Trivellin G; Gueorguiev M; Guegan K; Stals K; Khoo B; Kumar AV; Ellard S; Grossman AB; Korbonits M;
    Hum Mutat; 2010 Aug; 31(8):950-60. PubMed ID: 20506337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance.
    Bogner EM; Daly AF; Gulde S; Karhu A; Irmler M; Beckers J; Mohr H; Beckers A; Pellegata NS
    Int J Cancer; 2020 Dec; 147(12):3523-3538. PubMed ID: 32856736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro re-expression of the aryl hydrocarbon receptor (Ahr) in cultured Ahr-deficient mouse antral follicles partially restores the phenotype to that of cultured wild-type mouse follicles.
    Ziv-Gal A; Gao L; Karman BN; Flaws JA
    Toxicol In Vitro; 2015 Mar; 29(2):329-36. PubMed ID: 25500125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of the aip gene in familial pituitary tumorigenesis.
    Tahir A; Chahal HS; Korbonits M
    Prog Brain Res; 2010; 182():229-53. PubMed ID: 20541668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.